← Back to Search

sCBT for Anxiety Disorders

Phase 2 & 3
Waitlist Available
Led By Ellen Teng, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 3 month, 6 month follow ups
Awards & highlights

Study Summary

This study is evaluating whether a new form of cognitive behavioral therapy may help improve the quality of life for veterans with anxiety disorders.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 3 month, 6 month follow ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 3 month, 6 month follow ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
BAI: Comparison of Beck Anxiety Inventory Scores Among iCBT, sCBT, and TAU Groups From Baseline to 1, 3, and 6 Month Follow Ups
CRIS-EPS: Comparison of Extent of Participation Scores Among iCBT, sCBT, and TAU Groups From Baseline to 1, 3, and 6 Month Follow Ups
CRIS-PLS: Comparison of Perceived Limitation Scores Among iCBT, sCBT, and TAU Groups From Baseline to 1, 3, and 6 Month Follow Ups
+1 more
Secondary outcome measures
BDI-II: Comparison of Beck Depression Inventory Scores Among iCBT, sCBT, and TAU Groups From Baseline to 1, 3, and 6 Month Follow Ups
QLES-SF: Comparison of Quality of Life Enjoyment and Satisfaction Scores Among iCBT, sCBT, and TAU Groups From Baseline to 1, 3, and 6 Month Follow Ups

Trial Design

3Treatment groups
Active Control
Group I: sCBTActive Control1 Intervention
Patients in this arm will receive transdiagnostic CBT delivered in a standard weekly format for 12 weeks.
Group II: iCBTActive Control1 Intervention
Patients in this arm will receive transdiagnostic CBT delivered in an intensive format over one weekend.
Group III: TAUActive Control1 Intervention
Patients in this arm will not receive transdiagnostic CBT but will receive treatment as usual.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,304,925 Total Patients Enrolled
20 Trials studying Anxiety Disorders
2,539 Patients Enrolled for Anxiety Disorders
Ellen Teng, PhDPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX
5 Previous Clinical Trials
476 Total Patients Enrolled
2 Trials studying Anxiety Disorders
353 Patients Enrolled for Anxiety Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Transdiagnostic Cognitive Behavioral Treatment for Anxiety
2018. "Transdiagnostic Cognitive Behavioral Treatment for Anxiety". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03810456.
~54 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top